WALGREEN COMPANY for WALGREEN COMPANY
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Financial Institutions/Investments/Securities FIN
S. 575- the "Debit Interchange Fee Study Act of 2011"- all provisions regarding studying the market and appropriate regulatory structure for electronic debit card transactions. HR. 1081- the "Consumers Payment System Protection Act" -all provisions regarding delaying the implementation of proposed or final rules issued under the authority of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the reasonable and proportional fees and rules for electronic debit transactions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSAN DEVRIES | — |
| DEBBIE GARZA | — |
| EDWARD KALETA | — |
| HEATHER HERNDON SMITH | — |
Health Issues HCR
H.R. 2- the "Repealing the Job Killing Health Care Law Act"- any discussions or provisions regarding Average Manufacturer's Price (AMP) and medication therapy management (MTM). H.R. 2267/S. 227- the "Home Health Care Planning Improvement Act"- provisions related to payments for home health care services. H. Res. 9- the "Replace" bill- all provisions regarding the instruction of certain committees to report legislation replacing the job-killing health law, specifically with regards to discussions of Average Manufacturer's Price (AMP) and medication therapy management (MTM). H.R. 5-the "Help Efficient, Accessible, Low-Cost, Timely Healthcare (HEALTH) Act of 2011"-all provisions regarding capping damages at the greater of $250,000 or double the award of economic damages for certain health providers. H.R. 605/S. 312-the "Patient Freedom to Choose Act"-all provisions regarding repealing provisions of the Patient Protection and Affordable Care Act that restrict payments from health flexible spending arrangements for medications to prescription drugs and insulin. H.R. 2010/ S. 1098-the "Family and Retirement Health Investment Act of 2011"- provisions related to payments from a HSA/FSA for prescription and over-the-counter medicine or drugs. P.L. 111-148- the "Patient Protection and Affordable Care Act."-regarding the implementation of regulations of P.L. 111-148 including issues related to Average Manufacturer's Price (AMP), Medication Therapy Management (MTM), and employer coverage mandates.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEBBIE GARZA | — |
| EDWARD KALETA | — |
| HEATHER HERNDON SMITH | — |
Pharmacy PHA
Drug safety-no specific legislation-regarding any discussions surrounding the security of the drug supply chain. H.R.1540/S. 981- the "National Defense Authorization Act of FY 2012"- provisions related to the TRICARE program.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSAN DEVRIES | — |
| DEBBIE GARZA | — |
| EDWARD KALETA | — |
| HEATHER HERNDON SMITH | — |
Medicare/Medicaid MMM
S. 274- the "Medication Therapy Management Empowerment Act of 2011" -all provisions regarding amending the Medicare Modernization Act to expand eligibility of all targeted beneficiaries for access to Medication Therapy Management (MTM) in Medicare Part D. H.R. 1936- the "Medicare Access to Diabetes Supplies Act of 2011" -provisions related to the exemption from Medicare competitive acquisition programs of blood glucose self-testing equipment and supplies furnished by small retail community pharmacies. H.R. 2195/S. 1203- the "Medicare Home Infusion Therapy Coverage Act"- provisions related to the Medicare coverage of home infusion therapy and home infusion drugs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEBBIE GARZA | — |
| EDWARD KALETA | — |
| HEATHER HERNDON SMITH | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.